================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): August 24, 2004
Medicis Pharmaceutical Corporation
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18443 52-1574808
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification No.)
8125 North Hayden Road
Scottsdale, Arizona 85258-2463
(Address of Principal (Zip Code)
Executive Offices)
Registrant's telephone number, including area code: (602) 808-8800
N/A
--------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
Item 2.02 Results of Operations and Financial Condition
On August 24, 2004, Medicis Pharmaceutical Corporation (the "Company")
issued a press release regarding its fourth quarter and year-end fiscal 2004
financial results. A copy of the Company's press release is attached hereto as
Exhibit 99.1.
In accordance with general instruction B.2 to Form 8-K, the information
filed in this Form 8-K (including Exhibit 99.1) shall be deemed "furnished" and
not "filed" with the Securities and Exchange Commission for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not
incorporated by reference into any filing under the Securities Act of 1933, as
amended.
Item 9.01 Financial Statements and Exhibits
(a) Financial Statements of Business Acquired.
Not Applicable.
(b) Pro Forma Financial Information.
Not Applicable.
(c) Exhibits.
99.1 Copy of press release, dated August 24, 2004, issued by
Medicis Pharmaceutical Corporation
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICIS PHARMACEUTICAL CORPORATION
(Registrant)
Date: August 24, 2004 /s/ Mark A. Prygocki, Sr.
------------------------------------------
Name: Mark A. Prygocki, Sr.
Title: Executive Vice President, Chief
Financial Officer, Corporate
Secretary and Treasurer
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Copy of press release, dated August 24, 2004, issued by
Medicis Pharmaceutical Corporation.